- Home
- RELY vs PRCT Comparison
RELY vs PRCT Comparison
Compare RELY & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELY
- PRCT
- Stock Information
- Founded
- RELY 2011
- PRCT 2009
- Country
- RELY United States
- PRCT United States
- Employees
- RELY N/A
- PRCT N/A
- Industry
- RELY Computer Software: Prepackaged Software
- PRCT Medical Specialities
- Sector
- RELY Technology
- PRCT Health Care
- Exchange
- RELY Nasdaq
- PRCT Nasdaq
- Market Cap
- RELY 4.5B
- PRCT 4.7B
- IPO Year
- RELY 2021
- PRCT 2021
- Fundamental
- Price
- RELY $23.14
- PRCT $69.75
- Analyst Decision
- RELY Buy
- PRCT Strong Buy
- Analyst Count
- RELY 8
- PRCT 7
- Target Price
- RELY $23.13
- PRCT $97.86
- AVG Volume (30 Days)
- RELY 1.3M
- PRCT 656.5K
- Earning Date
- RELY 02-19-2025
- PRCT 02-25-2025
- Dividend Yield
- RELY N/A
- PRCT N/A
- EPS Growth
- RELY N/A
- PRCT N/A
- EPS
- RELY N/A
- PRCT N/A
- Revenue
- RELY $1,176,826,000.00
- PRCT $199,843,000.00
- Revenue This Year
- RELY $35.55
- PRCT $67.07
- Revenue Next Year
- RELY $24.22
- PRCT $40.64
- P/E Ratio
- RELY N/A
- PRCT N/A
- Revenue Growth
- RELY 35.18
- PRCT 71.71
- 52 Week Low
- RELY $11.60
- PRCT $44.52
- 52 Week High
- RELY $23.60
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- RELY 62.12
- PRCT 25.89
- Support Level
- RELY $22.11
- PRCT $79.56
- Resistance Level
- RELY $23.51
- PRCT $89.49
- Average True Range (ATR)
- RELY 0.57
- PRCT 4.14
- MACD
- RELY -0.08
- PRCT -1.11
- Stochastic Oscillator
- RELY 75.20
- PRCT 6.09
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.